Medicis Pharmaceutical Corporation (MRX) - Financial and Strategic SWOT Analysis Review

GlobalData, September 2011, Pages: 41

Medicis Pharmaceutical Corporation (MRX) - Financial and Strategic SWOT Analysis Review

Summary

Medicis Pharmaceutical Corporation (Medicis) is a pharmaceutical company engaged in development and marketing of pharmaceutical products for the treatment of dermatological and aesthetic conditions. The company focuses on helping its patients to attain a healthy and youthful appearance and self-image through its products. It offers a wide range of products addressing various therapeutic conditions, including acne, facial wrinkles, fungal infections, photoaging, psoriasis, rosacea, hyperpigmentation, seborrheic dermatitis and cosmesis. The company has its operations spread across the US, Canada and Europe. Currently, Medicis has 16 branded product offerings in the market including, DYSPORT, PERLANE, RESTYLANE, SOLODYN, VANOS and ZIANA, among others. The company is headquartered in Scottsdale, Arizona, the US.

Medicis Pharmaceutical Corporation Key Recent Developments

Aug 08, 2011 Medicis Reports Total Revenue Of $190.8m For Q2 2011
May 05, 2011 Medicis Pharmaceutical Reports Net Income Of $19.4m For Q1 2011
Feb 25, 2011 Medicis Reports Net Income Of $23.9m For Q4 2010
Nov 04, 2010 Medicis Reports Net Income Of $27.6 Million For Q3 2010
Aug 05, 2010 Medicis Reports Net Income Of $36.5 Million For Q2 2010

This comprehensive SWOT profile of Medicis Pharmaceutical Corporation provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

List of Tables
List of Figures
Section 1 - About the Company
Medicis Pharmaceutical Corporation - Key Facts
Medicis Pharmaceutical Corporation - Key Employees
Medicis Pharmaceutical Corporation - Key Employee Biographies
Medicis Pharmaceutical Corporation - Major Products and Services
Medicis Pharmaceutical Corporation - Pharmaceutical Pipeline Products Data
Medicis Pharmaceutical Corporation, Pipeline Products by Therapy Area
Medicis Pharmaceutical Corporation, Pipeline Products by Development Phase
Medicis Pharmaceutical Corporation - History
Medicis Pharmaceutical Corporation - Company Statement
Medicis Pharmaceutical Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Medicis Pharmaceutical Corporation - Business Description
Medicis Pharmaceutical Corporation - SWOT Analysis
SWOT Analysis - Overview
Medicis Pharmaceutical Corporation - Strengths
Strength - Sturdy Research and Development Effort
Strength - Strong Financial Performance
Strength - Broad Product Portfolio
Weakness - Increasing Reliance on Primary Products
Weakness - Confined Distributor Base
Weakness - Legal Proceedings
Opportunity - Research Collaborations
Opportunity - Product Approvals
Opportunity - Rising Healthcare Expenditure in the US
Threat - Intense Competition
Threat - Tightening of FDA’s Regulatory Oversight
Threat - Reimbursement Issues
Medicis Pharmaceutical Corporation - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Medicis Pharmaceutical Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Medicis Pharmaceutical Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
Medicis Pharmaceutical Corporation, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 08, 2011: Medicis Reports Total Revenue Of $190.8m For Q2 2011
May 05, 2011: Medicis Pharmaceutical Reports Net Income Of $19.4m For Q1 2011
Feb 25, 2011: Medicis Reports Net Income Of $23.9m For Q4 2010
Nov 04, 2010: Medicis Reports Net Income Of $27.6 Million For Q3 2010
Aug 05, 2010: Medicis Reports Net Income Of $36.5 Million For Q2 2010
Jul 22, 2010: Mylan Settles Minocycline Patent Litigation With Medicis
Jun 18, 2010: Medicis Announces Organizational Changes
May 26, 2010: Medicis Extends Dysport(R) Challenge; Over 90% Chose "love It"
May 05, 2010: Medicis Reports Net Income Of $35.4 Million For Q1 2010
Apr 27, 2010: Medicis Extends The Popular Dysport(Tm) Challenge By One Month
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Medicis Pharmaceutical Corporation, Key Facts
Medicis Pharmaceutical Corporation, Key Employees
Medicis Pharmaceutical Corporation, Key Employee Biographies
Medicis Pharmaceutical Corporation, Major Products and Services
Medicis Pharmaceutical Corporation, Number of Pipeline Products by Therapy Area
Medicis Pharmaceutical Corporation, Number of Pipeline Products by Development Stage
Medicis Pharmaceutical Corporation, Pipeline Products By Therapy Area and Development Phase
Medicis Pharmaceutical Corporation, History
Medicis Pharmaceutical Corporation, Subsidiaries
Medicis Pharmaceutical Corporation, Key Competitors
Medicis Pharmaceutical Corporation, Ratios based on current share price
Medicis Pharmaceutical Corporation, Annual Ratios
Medicis Pharmaceutical Corporation, Interim Ratios
Medicis Pharmaceutical Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Medicis Pharmaceutical Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
Medicis Pharmaceutical Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Medicis Pharmaceutical Corporation, Pipeline Products by Therapy Area
Medicis Pharmaceutical Corporation, Pipeline Products by Development Phase
Medicis Pharmaceutical Corporation, Performance Chart (2006 - 2010)
Medicis Pharmaceutical Corporation, Ratio Charts
Medicis Pharmaceutical Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Medicis Pharmaceutical Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2005 to YTD 2011

Warner Chilcott Plc
GlaxoSmithKline plc
Johnson & Johnson
Galderma Laboratories, LP
Allergan, Inc.
A.C. Moore Arts & Crafts, Inc.
Sanofi

Customers who bought this item also bought

• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• Scientific Games Corporation - Company Analysis
• eBay - Strong Execution
• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Hewlett-Packard Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Amazon - Point of Realization in 2013?
• Ixia - Company Analysis
• SunGard - Profile - US
• Insight into Samsung Electronics' Notebook PC Business Model
• US - Accenture - Company Profile